BRIEF-AstraZeneca to sell cancer medicine Caprelsa to Genzyme
July 27, 2015 at 02:13 AM EDT
* Entered into a definitive agreement with genzyme to divest Caprelsa (vandetanib), a rare disease medicine.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.